New CEO of Renamed Spin-Out Fortovia Therapeutics Will Be ‘Solely US-Focused’
Executive Summary
Newly installed Fortovia Therapeutics CEO Peter Melnyk tells Scrip his arrival and the company’s name change from Midatech Pharma US signals a strategic revamp for the privately held spin-out.